Tipiracil Impurity 4 | CAS 73742-45-7 - Request Quote
Tipiracil Impurity 4
| SZ CAT No: | SZ-T148007 |
| CAS No | 73742-45-7 |
| Mol.F. | C5H4Cl2N2O2 |
| Mol.Wt. | 195.0 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tipiracil Impurity 4 is chemically 5-Chloro-6-(chloromethyl)pyrimidine-2,4(1H,3H)-dione. Tipiracil Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Tipiracil Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tipiracil.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 73742-45-7
Purchase 73742-45-7
Order 73742-45-7
Enquire 73742-45-7
price of 73742-45-7
73742-45-7 Supplier
73742-45-7 Manufacturer
73742-45-7 Exporter
buy high quality Tipiracil Impurity 4
Purchase Tipiracil Impurity 4
Tipiracil Impurity 4 suppliers
Tipiracil Impurity 4 manufacturers
Tipiracil Impurity 4 price
Order Tipiracil Impurity 4
Enquire Tipiracil Impurity 4
Tipiracil Impurity 4 cost
Tipiracil Impurity 4 Supplier
Tipiracil Impurity 4 Distributor
Tipiracil Impurity 4 for Method Validation
Tipiracil Reference Standard
Tipiracil Impurity 4 for ANDA Filing
Tipiracil Impurity 4 for Forced Degradation Studies
Tipiracil Impurity 4 Identification Standards
Tipiracil Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.